Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by ZigZagon Oct 06, 2017 10:41am
83 Views
Post# 26785560

RE:RE:RE:we are not the only player here in our country.

RE:RE:RE:we are not the only player here in our country.It’s early days, and there’s still work to do to bring the benefits of this research to patients, but ultimately, we hope to help real doctors and clinics expand global screening capacity to cover all at-risk individuals in the world

So they are not ready. But we know that Diagnos is ready.  

They still have work to do to have their software ready. One, two year? And then, applied for a FDA approval,  and wait for the the anwer : an other one or two years...  Do many pilot tests with the approuved version of their software : an other year or two ...  It is what diagnos have done during the last decade...

This future competition is good for us as it shows to the health organisations that the science is at that level now. And with more than one player in the market with a disruptive technologie,  Diagnos won't look as a charlatan compagny.  It helps for the global awareness and to get a better rate of acceptance of our technology...  

Sorry for my english mistakes, i didn't used a translator for that post.  





Bullboard Posts